Lawmaker scrutiny

Actionable Insights Powered by AI

Lawmakers Scrutinize Pharma’s Telehealth Marketing Tactics Amid Concerns Over Patent Abuse and High Drug Prices

Pharma telehealth programs, Patent abuse, High drug prices, Lawmaker scrutiny, Pharmaceutical industry practices